ID18919A - Heterosikel sebagai penghambat pelekatan leukosit dan sebagai antagonis vla-4 - Google Patents

Heterosikel sebagai penghambat pelekatan leukosit dan sebagai antagonis vla-4

Info

Publication number: ID18919A
Authority: ID; Indonesia
Prior art keywords: leukosite; vla; heterocycle; antagonists; resistant
Prior art date: 1996-11-15

Application number

IDP973671A

Other languages

English (en)

Inventor

Hans Ulrich Dr Stilz

Volkmar Dr Wehner

Christoph Dr Huls

Dirk Dr Seiffge

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-15

Filing date

1997-11-13

Publication date

1998-05-20

1997-11-13 Application filed by Hoechst Ag filed Critical Hoechst Ag

1998-05-20 Publication of ID18919A publication Critical patent/ID18919A/id

Links

108010008212 Integrin alpha4beta1 Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)

IDP973671A 1996-11-15 1997-11-13 Heterosikel sebagai penghambat pelekatan leukosit dan sebagai antagonis vla-4 ID18919A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19647381A DE19647381A1 (de)	1996-11-15	1996-11-15	Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten

Publications (1)

Publication Number	Publication Date
ID18919A true ID18919A (id)	1998-05-20

Family

ID=7811831

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IDP973671A ID18919A (id)	1996-11-15	1997-11-13	Heterosikel sebagai penghambat pelekatan leukosit dan sebagai antagonis vla-4
IDP973672A ID18903A (id)	1996-11-15	1997-11-13	Heterosikles baru sebagai inhibitor dari penempelan leukosit dan sebagai bahan antagonis vla-4

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IDP973672A ID18903A (id)	1996-11-15	1997-11-13	Heterosikles baru sebagai inhibitor dari penempelan leukosit dan sebagai bahan antagonis vla-4

Country Status (29)

Country	Link
US (1)	US6838439B2 (id)
EP (1)	EP0842945B1 (id)
JP (1)	JP4101914B2 (id)
CN (1)	CN1129603C (id)
AR (1)	AR010065A1 (id)
AT (1)	ATE232881T1 (id)
AU (1)	AU736725B2 (id)
BR (1)	BR9705725B1 (id)
CA (1)	CA2220777C (id)
CZ (1)	CZ291733B6 (id)
DE (2)	DE19647381A1 (id)
DK (1)	DK0842945T3 (id)
ES (1)	ES2191803T3 (id)
HR (1)	HRP970604B1 (id)
HU (1)	HUP9702036A3 (id)
ID (2)	ID18919A (id)
IL (1)	IL122187A (id)
MX (1)	MX9708780A (id)
MY (1)	MY123865A (id)
NO (1)	NO975246L (id)
NZ (1)	NZ329176A (id)
PL (1)	PL323129A1 (id)
PT (1)	PT842945E (id)
RU (1)	RU2213097C2 (id)
SI (1)	SI0842945T1 (id)
SK (1)	SK284287B6 (id)
TR (1)	TR199701355A2 (id)
TW (1)	TW567184B (id)
ZA (1)	ZA9710246B (id)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19647380A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19741235A1 (de) *	1997-09-18	1999-03-25	Hoechst Marion Roussel De Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) *	1997-09-23	1999-03-25	Hoechst Marion Roussel De Gmbh	Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de)	1997-11-19	1999-05-20	Hoechst Marion Roussel De Gmbh	Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
US6329372B1 (en)	1998-01-27	2001-12-11	Celltech Therapeutics Limited	Phenylalanine derivatives
ATE273273T1 (de)	1998-02-26	2004-08-15	Celltech Therapeutics Ltd	Phenylalaninderivate als inhibitoren von alpha4 integrinen
GB9805655D0 (en)	1998-03-16	1998-05-13	Celltech Therapeutics Ltd	Chemical compounds
US6521626B1 (en)	1998-03-24	2003-02-18	Celltech R&D Limited	Thiocarboxamide derivatives
DE19821483A1 (de) *	1998-05-14	1999-11-18	Hoechst Marion Roussel De Gmbh	Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
GB9811159D0 (en)	1998-05-22	1998-07-22	Celltech Therapeutics Ltd	Chemical compounds
GB9811969D0 (en) *	1998-06-03	1998-07-29	Celltech Therapeutics Ltd	Chemical compounds
GB9812088D0 (en)	1998-06-05	1998-08-05	Celltech Therapeutics Ltd	Chemical compounds
GB9814414D0 (en)	1998-07-03	1998-09-02	Celltech Therapeutics Ltd	Chemical compounds
SK2612001A3 (en) *	1998-08-26	2001-11-06	Aventis Pharma Ltd	Aza-bicycles which modulate the inhibition of cell adhesion
GB9818641D0 (en) *	1998-08-26	1998-10-21	Rh Ne Poulenc Rorer Limited	Chemical compounds
GB9821061D0 (en)	1998-09-28	1998-11-18	Celltech Therapeutics Ltd	Chemical compounds
GB9821222D0 (en)	1998-09-30	1998-11-25	Celltech Therapeutics Ltd	Chemical compounds
GB9825652D0 (en)	1998-11-23	1999-01-13	Celltech Therapeutics Ltd	Chemical compounds
GB9826174D0 (en)	1998-11-30	1999-01-20	Celltech Therapeutics Ltd	Chemical compounds
ES2297943T3 (es)	1998-12-23	2008-05-01	Aventis Pharma Limited	Dihidro-benzo(1,4)oxacinas y tetrahidroquinoxalinas.
CA2361162A1 (en) *	1999-03-01	2000-09-08	Elan Pharmaceuticals, Inc.	Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7-receptor antagonists
ATE281433T1 (de)	1999-05-05	2004-11-15	Aventis Pharma Ltd	Substituierte pyrrolidine als inhibitoren der zelladhäsion
DE19922462A1 (de) *	1999-05-17	2000-11-23	Aventis Pharma Gmbh	Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6518283B1 (en)	1999-05-28	2003-02-11	Celltech R&D Limited	Squaric acid derivatives
EE200200070A (et)	1999-08-13	2003-04-15	Biogen, Inc.	Raku adhesiooni inhibiitorid
US6534513B1 (en)	1999-09-29	2003-03-18	Celltech R&D Limited	Phenylalkanoic acid derivatives
US6455539B2 (en)	1999-12-23	2002-09-24	Celltech R&D Limited	Squaric acid derivates
EA004673B1 (ru)	1999-12-28	2004-06-24	Пфайзер Продактс Инк.	Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
DE60130910T2 (de)	2000-04-17	2008-07-10	Ucb Pharma, S.A.	Enamin-derivate als zell-adhäsionsmoleküle
US6545013B2 (en)	2000-05-30	2003-04-08	Celltech R&D Limited	2,7-naphthyridine derivatives
US6403608B1 (en)	2000-05-30	2002-06-11	Celltech R&D, Ltd.	3-Substituted isoquinolin-1-yl derivatives
JP2004516237A (ja)	2000-06-21	2004-06-03	ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー	ケモカイン受容体活性調節剤としてのピペリジンアミド類
JP2004502762A (ja)	2000-07-07	2004-01-29	セルテック　アール　アンド　ディ　リミテッド	二環性ヘテロ芳香環を含有するインテグリンアンタゴニストとしてのスクエア酸誘導体
JP2004505110A (ja)	2000-08-02	2004-02-19	セルテック　アール　アンド　ディ　リミテッド	３位置換イソキノリン−１−イル誘導体
ATE524441T1 (de)	2000-12-28	2011-09-15	Daiichi Seiyaku Co	Vla-4-inhibitoren
DE10111877A1 (de)	2001-03-10	2002-09-12	Aventis Pharma Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10137595A1 (de)	2001-08-01	2003-02-13	Aventis Pharma Gmbh	Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
TW200307671A (en) *	2002-05-24	2003-12-16	Elan Pharm Inc	Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) *	2002-05-24	2007-05-21	Elan Pharm Inc	Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
AU2003267991B2 (en) *	2002-07-11	2009-10-08	Vicuron Pharmaceuticals, Inc.	N-hydroxyamide derivatives possessing antibacterial activity
WO2005009992A1 (ja)	2003-07-24	2005-02-03	Daiichi Pharmaceutical Co., Ltd.	シクロヘキサンカルボン酸類
EP2510941A3 (en)	2007-02-20	2013-01-23	Merrimack Pharmaceuticals, Inc.	Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
BRPI0911652A2 (pt)	2008-04-11	2015-08-04	Merrimack Pharmaceuticals Inc	Ligantes de albumina sérica humana e seus conjugados
WO2009131957A2 (en)	2008-04-21	2009-10-29	Institute For Oneworld Health	Compounds, compositions and methods comprising oxadiazole derivatives
US8236838B2 (en) *	2008-04-21	2012-08-07	Institute For Oneworld Health	Compounds, compositions and methods comprising isoxazole derivatives
US20090270398A1 (en) *	2008-04-21	2009-10-29	Institute For Oneworld Health	Compounds, Compositions and Methods Comprising Pyridazine Derivatives
WO2009131958A2 (en) *	2008-04-21	2009-10-29	Institute For Oneworld Health	Compounds, compositions and methods comprising triazine derivatives
WO2010033626A1 (en) *	2008-09-19	2010-03-25	Institute For Oneworld Health	Compounds, compositions and methods comprising imidazole and triazole derivatives
DE102009012314A1 (de)	2009-03-09	2010-09-16	Bayer Schering Pharma Aktiengesellschaft	Oxo-heterocyclisch substituierte Alkylcarbonsäuren und ihre Verwendung
US8511216B2 (en) *	2009-03-30	2013-08-20	Kanzaki Kokyukoki Mfg. Co., Ltd.	Hydraulic actuator unit
US8343976B2 (en) *	2009-04-20	2013-01-01	Institute For Oneworld Health	Compounds, compositions and methods comprising pyrazole derivatives
US20120258093A1 (en)	2009-08-20	2012-10-11	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
WO2012061074A1 (en)	2010-10-25	2012-05-10	Elan Pharmaceuticals, Inc.	METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
US20240301512A1 (en)	2021-01-29	2024-09-12	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL136473C (id) *	1968-02-19
DE4124942A1 (de)	1991-07-27	1993-01-28	Thomae Gmbh Dr K	5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
WO1993013798A1 (en)	1992-01-13	1993-07-22	Biogen, Inc.	Treatment for asthma
WO1993017033A1 (en) *	1992-02-19	1993-09-02	The Biomembrane Institute	Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto
DE4224414A1 (de)	1992-07-24	1994-01-27	Cassella Ag	Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
JPH08505628A (ja)	1993-01-08	1996-06-18	田辺製薬株式会社	ペプチド型細胞接着阻害薬
DE4427979A1 (de) *	1993-11-15	1996-02-15	Cassella Ag	Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
WO1995015973A1 (en) *	1993-12-06	1995-06-15	Cytel Corporation	Cs-1 peptidomimetics, compositions and methods of using the same
CA2193828A1 (en)	1994-06-29	1996-01-11	Timothy P. Kogan	Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
US5586473A (en)	1994-07-20	1996-12-24	Mei-Chi-Na Beauty International, Inc.	Integrated needle for permanent pigment applicator
US5811391A (en)	1994-08-25	1998-09-22	Cytel Corporation	Cyclic CS-1 peptidomimetics, compositions and methods of using same
GB9524630D0 (en)	1994-12-24	1996-01-31	Zeneca Ltd	Chemical compounds
US6306840B1 (en) *	1995-01-23	2001-10-23	Biogen, Inc.	Cell adhesion inhibitors
DE19515177A1 (de)	1995-04-28	1996-10-31	Cassella Ag	Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe
US5710159A (en)	1996-05-09	1998-01-20	The Dupont Merck Pharmaceutical Company	Integrin receptor antagonists
ES2171768T3 (es)	1996-03-20	2002-09-16	Hoechst Ag	Inhibidores de la resorcion osea y antagonistas de receptores de vitronectina.
DE19647382A1 (de)	1996-11-15	1998-05-20	Hoechst Ag	Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten

1996
- 1996-11-15 DE DE19647381A patent/DE19647381A1/de not_active Withdrawn
1997
- 1997-11-10 SI SI9730499T patent/SI0842945T1/xx unknown
- 1997-11-10 DE DE59709342T patent/DE59709342D1/de not_active Expired - Lifetime
- 1997-11-10 DK DK97119636T patent/DK0842945T3/da active
- 1997-11-10 AT AT97119636T patent/ATE232881T1/de active
- 1997-11-10 PT PT97119636T patent/PT842945E/pt unknown
- 1997-11-10 EP EP97119636A patent/EP0842945B1/de not_active Expired - Lifetime
- 1997-11-10 ES ES97119636T patent/ES2191803T3/es not_active Expired - Lifetime
- 1997-11-12 CA CA2220777A patent/CA2220777C/en not_active Expired - Fee Related
- 1997-11-13 ZA ZA9710246A patent/ZA9710246B/xx unknown
- 1997-11-13 CZ CZ19973601A patent/CZ291733B6/cs not_active IP Right Cessation
- 1997-11-13 TW TW086116880A patent/TW567184B/zh active
- 1997-11-13 ID IDP973671A patent/ID18919A/id unknown
- 1997-11-13 MY MYPI97005428A patent/MY123865A/en unknown
- 1997-11-13 IL IL122187A patent/IL122187A/en not_active IP Right Cessation
- 1997-11-13 SK SK1527-97A patent/SK284287B6/sk unknown
- 1997-11-13 NZ NZ329176A patent/NZ329176A/xx unknown
- 1997-11-13 AU AU45155/97A patent/AU736725B2/en not_active Ceased
- 1997-11-13 RU RU97119626/04A patent/RU2213097C2/ru not_active IP Right Cessation
- 1997-11-13 ID IDP973672A patent/ID18903A/id unknown
- 1997-11-13 HR HR970604A patent/HRP970604B1/xx not_active IP Right Cessation
- 1997-11-13 TR TR97/01355A patent/TR199701355A2/xx unknown
- 1997-11-13 AR ARP970105300A patent/AR010065A1/es active IP Right Grant
- 1997-11-14 JP JP32970397A patent/JP4101914B2/ja not_active Expired - Fee Related
- 1997-11-14 MX MX9708780A patent/MX9708780A/es not_active IP Right Cessation
- 1997-11-14 NO NO975246A patent/NO975246L/no not_active Application Discontinuation
- 1997-11-14 BR BRPI9705725-8A patent/BR9705725B1/pt not_active IP Right Cessation
- 1997-11-14 HU HU9702036A patent/HUP9702036A3/hu unknown
- 1997-11-14 CN CN97122685A patent/CN1129603C/zh not_active Expired - Fee Related
- 1997-11-15 PL PL97323129A patent/PL323129A1/xx unknown
2001
- 2001-11-29 US US09/995,631 patent/US6838439B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP4101914B2 (ja)	2008-06-18
ZA9710246B (en)	1998-05-15
EP0842945B1 (de)	2003-02-19
IL122187A (en)	2006-04-10
US20020065391A1 (en)	2002-05-30
DE59709342D1 (de)	2003-03-27
AU4515597A (en)	1998-05-21
MX9708780A (es)	1998-08-30
SK284287B6 (sk)	2005-01-03
NO975246L (no)	1998-05-18
AU736725B2 (en)	2001-08-02
PL323129A1 (en)	1998-05-25
HRP970604B1 (en)	2003-10-31
AR010065A1 (es)	2000-05-17
IL122187A0 (en)	1998-04-05
NZ329176A (en)	1999-03-29
SI0842945T1 (en)	2003-06-30
CN1129603C (zh)	2003-12-03
HUP9702036A3 (en)	1998-12-28
TR199701355A3 (tr)	1998-06-22
TW567184B (en)	2003-12-21
HUP9702036A1 (hu)	1998-07-28
MY123865A (en)	2006-06-30
BR9705725B1 (pt)	2009-01-13
CA2220777A1 (en)	1998-05-15
BR9705725A (pt)	1999-11-23
CZ291733B6 (cs)	2003-05-14
EP0842945A3 (de)	1999-02-24
SK152797A3 (en)	1998-06-03
TR199701355A2 (xx)	1998-06-22
RU2213097C2 (ru)	2003-09-27
CA2220777C (en)	2012-05-29
ID18903A (id)	1998-05-20
HU9702036D0 (en)	1998-01-28
NO975246D0 (no)	1997-11-14
US6838439B2 (en)	2005-01-04
CZ360197A3 (cs)	1998-06-17
PT842945E (pt)	2003-07-31
HRP970604A2 (en)	1998-08-31
ES2191803T3 (es)	2003-09-16
CN1182746A (zh)	1998-05-27
DK0842945T3 (da)	2003-06-10
DE19647381A1 (de)	1998-05-20
JPH10158298A (ja)	1998-06-16
ATE232881T1 (de)	2003-03-15
EP0842945A2 (de)	1998-05-20

Publication	Publication Date	Title
ID19010A (id)	1998-06-04	Cincin heterosiklik beranggota-5 sebagai inhibitor pelekatan leukosit dan sebagai antagonis vla-4
ID26099A (id)	2000-11-23	Turunan amida dan antagonis nosiseptin
ID18903A (id)	1998-05-20	Heterosikles baru sebagai inhibitor dari penempelan leukosit dan sebagai bahan antagonis vla-4
ID17767A (id)	1998-01-22	Vaksin dan polipeptida-polipeptida sampul hiv
ID18003A (id)	1998-02-19	Antagonis muskarinik
DE69835245D1 (de)	2006-08-24	Therapeutische Zusammensetzungen, enthaltend Amlodipin und Atorvastatin
ID22711A (id)	1999-12-09	Atropisomer dari 3-aril-4(3h)-kinazolinon dan penggunaannya sebagai antagonis reseptor-ampa
ID22594A (id)	1999-11-25	Alat dan cara penjerapan putar tekanan
EE03974B1 (et)	2003-02-17	Asendis 5 ja 6 modifitseeritud GnRH antagonistid
ID25504A (id)	2000-10-05	Pencegahan dan pengobatan penyakit amiloidogenik
BR9702994A (pt)	1999-07-20	Composição auto-espumante dispositivo aerosol e utilização de um composição
ID26248A (id)	2000-12-07	Turunan asiguanidina baru sebagai inhibitor penyerapan tulang dan sebagai antagonis reseptor vitronektin
ID23433A (id)	2000-04-20	Keistimewaan kunci dan anti-tersumbat untuk kemasan semprotan
PL339617A1 (en)	2001-01-02	Novel antagonists of neuropeptide y
NO995500L (no)	1999-11-10	Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi
ID20895A (id)	1999-03-25	Senyawa-senyawa piperazina dan piperidina baru
ID26665A (id)	2001-01-25	Antagonis vla-4
ID17773A (id)	1998-01-29	Metode dan alat untuk memurnikan suatu bahan
ID24270A (id)	2000-07-13	Penghilang sumbatan keratotik
ID20802A (id)	1999-03-04	Metode pencegahan ledakan debu sulfida setelah penghancuran
ID23437A (id)	2000-04-20	Penghilang sumbatan keratotik
IT244003Y1 (it)	2002-03-07	Tenuta d'albero
FR2757510B1 (fr)	2000-01-07	Forme microparticulaire d'un derive de tetrahydropyridine
ID19739A (id)	1998-07-30	Antagonis penerima benzimidazolil neuropeptida y
PL336847A1 (en)	2000-07-17	Hiv protease inhibitor sulphate of improved absorption after oral administration and of improved bioavailability